Financial Statements Statements of Cash Flows for the year ended 31 December 2024 Group Company Note 2024 RM’mil 2023 RM’mil 2024 RM’mil 2023 RM’mil Cash flows from operating activities Profit before tax 3,756 4,049 1,121 1,374 Adjustments for: Dividend income 22 (1) – (1,215) (621) Finance income 24 (273) (102) (4) (8) Finance costs 24 1,065 941 – – Depreciation and impairment of property, plant and equipment 3 1,247 1,073 – – Depreciation of right-of-use assets 4 434 391 – 1 Amortisation of intangible assets 6 53 48 – – Impairment loss made: − Trade and other receivables 25 70 99 – – Write-off: − Property, plant and equipment – 2 – – − Trade and other receivables 36 14 – – − Inventories 6 7 – – Gain on disposal of property, plant and equipment (8) (11) – – Gain on disposal of subsidiaries 25 – (991) – (827) Gain on disposal of interests in associates 25 – (4) – – Gain on disposal of assets (15) (2) – – Change in fair value of investment properties 25 (207) (9) – – Reversal of provision for loan taken by a joint venture 25 (27) – – – Share of profits of associates (net of tax) (26) (25) – – Share of profits of joint ventures (net of tax) (3) (1) – – Equity-settled share-based payments 5 8 2 3 Net monetary gain arising from hyperinflationary economy (489) (704) – – Operating profit/(loss) before changes in working capital 5,623 4,783 (96) (78) Changes in working capital: Development properties – (2) – – Inventories (111) (193) – – Trade and other receivables (1,690) (550) (133) (50) Trade and other payables 1,086 375 5 (31) Cash generated from/(used in) operations 4,908 4,413 (224) (159) Tax paid (623) (654) (2) (4) Net cash from/(used in) operating activities 4,285 3,759 (226) (163) The notes on pages 136 to 236 are an integral part of these financial statements. IHH Healthcare Berhad | Annual Report 2024 134
RkJQdWJsaXNoZXIy NDgzMzc=